Where to next for G8 Education Ltd and Affinity Education Group Ltd?

Investors will wonder what's happening between G8 Education Ltd (ASX:GEM) and Affinity Education Group ltd (ASX:AFJ) after a market-sensitive update this morning.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Regular readers may have seen my article on the Affinity-G8 tie-up last week, when I wrote that the rejected takeover offer was a blessing in disguise for G8 Education Ltd (ASX: GEM) shareholders.

This morning, Affinity Education Group Ltd (ASX: AFJ) released a market-sensitive announcement indicating that they had hired independent advisors to 'assist the board in its assessment of G8 Education's proposed offer.'

Wait, what?

Just a few days ago, Affinity knocked back G8's offer out of hand, arguing that it was opportunistic and undervalued the company.

Is Affinity now thinking about the proposal?

It certainly looks like it; or at least they may be trying to value the company to determine if the takeover offer is in fact a fair one. In recent days G8 Education has upped its shareholding in Affinity to 19.89%, making it the largest single shareholder in the company.

The plot thickens…

As it happens, this is actually the third offer that G8 Education has made for Affinity, with both previous occasions involving a 'nil-premium merger' where G8 would acquire Affinity in return for shares. The previous offers (based on G8's share price at the time) valued Affinity at approximately $1.105 (in April) and $0.825 (in June).

Both companies had agreed to meet on 4 July to discuss the most recent proposal, but G8 snapped up a slice of Affinity and made its most recent offer, at $0.69 per share, before talks could be held. This prompted Affinity management to reject the takeover as opportunistic.

So, where to next?

Well, with G8 increasing its stake in Affinity it looks as though the company is determined to get the deal across the line. However, as Affinity management pointed out, G8 was recently prepared to pay a substantially higher premium for the company and in this light investors are probably less likely to accept the offer.

Surprisingly, shares in both companies have declined in trade so far today and it looks as though G8 shareholders are nervous about the potential deal while Affinity owners aren't confident a better offer will materialise.

A higher price?

A decision by G8 to pay a higher price for Affinity would be a terrible outcome for G8 shareholders, and would be a strong catalyst to prompt a rethink of my shareholding in the company.

The whole point of a roll-up company is to acquire privately held businesses, buy them at a cheap multiple around 3-4x annual earnings, and then effectively 'sell' them to shareholders in the form of share issues (which fund the purchases) for a higher Price to Earnings (P/E) multiple of say 12 or higher.

When share prices start to fall or the acquisitions aren't great, the strategy can unravel because the company stops performing as expected. G8 paying a higher price for Affinity's average centres (below 80% occupancy) could become an example of this.

Furthermore because G8 operates in a labour-intensive service industry (childcare) there are limited synergies that can be achieved by getting bigger. Acquiring Affinity would allow a reduction in management headcount and a few other areas, but neither company's centres will miraculously serve more children or generate an increase in revenue proportional to the size of the acquisition.

G8 is already offering a high price in terms of a greater number of shares required to buy Affinity (because G8's share price is down), so a decision to pay more for Affinity would dilute earnings even further without the potential for organic earnings growth to justify it.

Investors looking enviously at G8's depressed price and sky-high dividend yield may be better off focusing on other companies for the time being.

Motley Fool contributor Sean O'Neill owns shares of G8 Education Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »